首页 › 镰状细胞病 › 哥伦比亚特区 › Washington
Washington DC 镰状细胞病临床试验
19项针对 镰状细胞病的研究正在 Washington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Blood Sampling for Research Related to Sickle Cell Disease
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
招募中早期 I 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
招募中3 期
- Childrens National Hospital, Washington D.C.
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
招募中3 期
- Childrens National Medical Ctr, Washington D.C.
- MedStar Hlth Res Institute, Washington D.C.
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
招募中1 期
- National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda · 距离 7 英里
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
招募中观察性研究
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
招募中2 期
- Center for Cancer and Blood Disorders, Bethesda · 距离 7 英里
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
招募中观察性研究
- Children's National Hospital (MRD-HCT), Washington D.C.
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
招募中2 期
- Children's National Hospital, Washington D.C.
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
招募中2 期
- Children's National Health System, Washington D.C.
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
招募中2 期
- Children's National Hospital, Washington D.C.
Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
招募中
- Children's National Hospital, Washington D.C.
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
招募中
- Children's National Hospital, Washington D.C.
其他城市的 镰状细胞病试验
- Atlanta, GA21 项研究
- Memphis, TN18 项研究
- Chicago, IL18 项研究
- Philadelphia, PA15 项研究
- Birmingham, AL14 项研究
- New York City, NY13 项研究
- St. Louis, MO12 项研究
- Boston, MA10 项研究
- Durham, NC10 项研究
- Houston, TX10 项研究
- Cincinnati, OH10 项研究
- Columbus, OH9 项研究
Washington的其他研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌55 项研究
- 乳腺癌46 项研究
- 转移性癌症43 项研究
- 肺癌41 项研究
- 前列腺癌38 项研究
- 肥胖症33 项研究
- 结直肠癌29 项研究
- 心血管疾病28 项研究
- 膀胱癌26 项研究
- 急性髓系白血病24 项研究
- 淋巴瘤23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月7日。每项研究自行设定入选标准，由研究团队决定谁能参与。